| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $529.3M | +3.6% |
| Cost of Revenue | $296.5M | -8.3% |
| Gross Profit | $232.8M | +24.2% |
| R&D Expense | $73.7M | +0.6% |
| SG&A Expense | $66.1M | -8.4% |
| Operating Income | $6.1M | +117.4% |
| Pre-tax Income | $15.7M | +153.3% |
| Income Tax | $741K | -32.1% |
| Net Income | $14.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146.4M | +78.5% |
| Accounts Receivable | $39.7M | -30.8% |
| Inventory | $41.2M | +1.4% |
| Current Assets | $260.5M | -0.8% |
| Total Assets | $310.5M | +4.1% |
| Current Liabilities | $172.3M | -2.5% |
| Total Liabilities | $182.7M | -7.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $78.7M | +53.4% |
| Investing Cash Flow | $27.8M | +156.0% |
| Financing Cash Flow | -$42.1M | -3.2% |
| +148.9% |
| EPS (Basic) | $0.14 | +145.2% |
| EPS (Diluted) | $0.14 | +145.2% |
| Stockholders' Equity |
| $127.8M |
| +26.7% |